ArticleBiotechnology and bioengineering2021
Accelerating and de-risking CMC development with transposon-derived manufacturing cell lines.
Sowmya Rajendran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it